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1. Introduction
We have learned that genes in mammalian cells are transcribed into messenger 
RNAs (mRNAs), which are to be translated into polypeptides (proteins). This is 
known as “Central Dogma.” Gene expression must be appropriately maintained 
to regulate development, differentiation, and proliferation of cells. Imbalances or 
disturbances in gene expression are sometimes deleterious for living things. For 
example, steroid and thyroid hormones directly bind to nuclear receptors, which 
induce expression of specific genes. Recent global analyses of gene transcripts 
revealed that specific transcription factors (TFs) and their networking systems 
physiologically correspond to the onset of human diseases, including cancer. In 
other words, expression of specific genes might have relevance to pathogenesis 
of diseases. Given that OKSM (Yamanaka) factors convert somatic cells into 
induced pluripotent stem (iPS) cells, alterations in transcriptional state could 
affect destiny of the cells. In this chapter, revisiting known TFs, we would argue 
if transcription controlling strategies could contribute for the novel therapies on 
human diseases.
2. Transcription factors (TFs) in mammalian cells
Transcription factors are divided into two groups. First, the general TFs (GTFs), 
including preinitiation complex components TFIIA, TFIIB, TFIID, TFIIE, TFIIF, 
and THIIH, are the primary protein factors that are required for the initiation of 
transcription from the TATA box (or TATA element), then elongation is executed by 
RNA polymerase II (RNA pol II) [1]. The others are the site-specific TFs or the DNA 
sequence-specific binding proteins.
2.1 The GTFs and TATA-less promoters
Molecular mechanisms of the initiation of transcription from TATA box 
have been well known as the most essential nuclear events in mammalian cells. 
However, about 70% of mammalian gene promoters have no TATA or TATA-like 
elements, and they are referred to as TATA-less promoters [2]. In yeast cells, most 
of genes are regulated by the same general TF-dependent system independent 
of TATA or TATA-like sequences [3]. TATA-containing and TATA-less promoters 
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are different in the distribution of the A-tracts, G-quadruplex, and CpG islands 
[4]. Given that most of the housekeeping genes are controlled by TATA or TATA-
like elements, TATA-less promoters would be sensitive to the environments in 
response to various stresses. For example, some of the TATA-less promoters have 
DTIE binding sites [5]. The duplicated GGAA (TTCC) elements are frequently 
found near the transcription start sites (TSSs) of the human TATA-less promot-
ers [6], implying that GGAA (TTCC) binding TFs contribute to the initiation of 
transcription.
2.2 The site-specific transcription factors
Transcription mediator interplays with the transcription activator proteins 
and the GTFs to enable plasticity and flexibility of gene expression [7]. However, 
site-specific TF-mediated and TATA-independent transcription system should be 
investigated because it may control responses to stresses. The TFs are categorized by 
their amino acid sequences or domain structures according to TRANSFAC (www.
edgar-wingender.de/huTF_classification.html) database [8]. Some proteins might 
have multiple characteristic motifs.
2.2.1 Basic helix-loop-helix (bHLH) proteins
The bHLH proteins contain a basic region and HLH motif, which is comprised 
of two α-helices separated by a loop [9]. The bHLH family, BMAL, C/EBP, CLOCK, 
c-MYC, MYOD, NPAS2, and SREBP1/2, regulates development of mesodermal and 
neural tissues.
2.2.2 Helix-turn-helix (HTH) proteins
The ETS, FOX, IRF, HOX, HSF, POU, and PAX proteins belong to the HTH pro-
tein group. The HTH domains are present in NANOG, OCT1, PDN, and FLI1 [10]. 
ETS family proteins [11–13], which bind to GGAA (TTCC)-core motifs, contain 
ETS domain [14]. They regulate oncogenesis, development, differentiation, and 
apoptosis. The homeodomain (HD) is classified into 16 major subclasses, including 
ANTP, HNF, POU, PRD, SIX/SO, and ZF [15]. The HD proteins, including OTFs 
[16], which consist about 15–30% of TFs in animals, regulate differentiation and 
development of organisms.
2.2.3 High-mobility group (HMG) proteins and heteromeric CCAAT-binding 
factors
This group includes SOX [17] and NF-Y [18] proteins. They are thought to be the 
key TFs to regulate differentiation of cells, development of organs, and aging.
2.2.4 Immunoglobulin-fold proteins
This group, including NF-κB, IκB, NFAT, STAT, and p53, plays roles in transduc-
tion of biologically important signals to nuclei in response to cytokine-induced 
stimulation, viral infection, DNA-damage, and nutrients.
2.2.5 Leucine zipper proteins (bZIP)
The bZIP family includes CREB/ATF, BACH1/2, and FOS/JUN. The FOS/JUN 
has been originally characterized as product of the proto-oncogene or immediate 
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early gene, which very quickly responds to neuronal stimulatory or cellular prolifer-
ation-inducing signals [19].
2.2.6 Zinc finger motif containing proteins
The zinc finger motifs, which could be separated into major two classes, (1) Cys4 
and (2) Cys2His2, are the major motifs in numbers of TFs and DNA binding proteins 
[20].
1. The Cys4-type proteins, including GRs, ERs, RARs, CREBBP, IGHMBP2, 
GATA, PPAR, are classified into zinc fingers ZZ (ZZZ), zinc fingers AN1 
(ZFAND), and GATA zinc-finger domain-containing (GATAD) types.
2. The Cys2His2, or the zinc fingers C2H2 (ZNF) type, is the typical motif in 
the mammalian TFs. SP1, KLF4, KLF5, EGR3, and numbers of ZNF proteins 
belong to this class.
2.2.7 β-Structure (β-scaffold, β-sheet, and β-barrel) containing transcription 
factors
This group includes DBP, NF-1, HMGA, SMAD, and TBP. The RNase II and 
DNA glycosylases carry common motif, TBP-domain. The origin is thought to trace 
back to before the divergence of the three domains of life, bacteria, archaea, and 
eukaryote [21].
The classification implies that TATA-dependent initiation is not the standard 
but one of the site-specific transcriptions. For correct understanding of the cellular 
responses to differentiation/development-inducing signals, it should be examined 
how the site-specific TFs could initiate transcription.
3. Stresses and signals that regulate gene expression
Water-insoluble factors, steroids, and vitamins will easily go through lipid 
bilayer to bind to nuclear receptors. On the other hand, water-soluble compounds 
bind to the membrane receptors to transfer signals into cells, causing prompt 
response to induce certain signal cascade [22] to enhance/suppress specific gene 
expression as follows:
1. cyclic AMP (protein kinase A) pathway
2. MAP kinase pathways
3. Wnt signaling
4. TGFβ signaling
5. JAK/STAT pathway
6. Toll-like receptor signaling
7. immunoreceptor signaling
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Cells are continuously receiving stresses, which are, for example, temperature, 
lights and radiations, proton and ionic gradient, nutrients, and pathogens, including 
bacteria and viruses. Therefore, responses to these stresses are essential for life [23]. 
The stress-induced signals will be converted to cellular responses, including secre-
tion, gating ion channels, cellular behavior, proliferation, differentiation, senescence, 
apoptosis, and the development of organs. Some of the signals cause epigenetic 
changes or affect transcription of specific genes. We should remember that DNA 
methylations are required for setting accurate TSSs [24]. The epigenetic modification 
of DNAs, such as methylation, acetylation, and phosphorylation, and poly(ADP-
ribosyl)ation, is dependent on the substrate molecules, S-adenosyl methionine, 
acetyl-CoA, ATP, and NAD+, respectively [25]. They are the metabolites that we have 
learned from textbooks in biological chemistry. These molecules are so essential and 
indispensable for living things that they must be obtained from metabolism of nucleic 
acids, amino acids, lipids, and carbohydrates. Not only the epigenetic regulation, but 
also transcription is dependent on nutrients or the metabolites. For example, AMPK-
FOXO pathway plays a role as a nutrient sensor to affect gene expression [26]. The 
AMPK has been shown to regulate NADPH homeostasis during energy stress [27]. 
Increased NAD+/NADH ratio serves as a metabolic switch for transcription of the 
BRCA1 gene [28]. The transcriptional corepressor protein, CtBP1, which possesses an 
NADH binding domain [29, 30], is one of the candidates that play a role in the NAD+/
NADH ratio-dependent transcription system. Importantly, several human DNA-
repair-factor encoding gene promoters respond to natural compound trans-resvera-
trol (Rsv), which upregulates NAD+/NADH ratio in HeLa S3 cells [31], implying that 
expression of the DNA-repair associated genes is partly regulated by metabolic state.
4. Analyses of gene expression in human diseases
The next-generation sequencing (NGS) analysis greatly contributed for the 
identification of specific genetic errors [32]. Somatic mutations on cancer driver 
genes have been identified [33, 34] and the statistical data contribute for the 
prediction or diagnosis of cancer. In search of biomarkers and cancer-causing 
factors, transcriptome analyses have been applied on model animals and clinical 
samples from patients, gradually unveiling mechanisms of the cancer progression. 
Hot spot somatic mutations are observed in the promoter regions of the human 
cancer genomes [35]. Binding of the TFs on the promoter could regulate mutation 
rate to modulate both transcription and DNA-repair systems [36]. In melanomas, 
such mutations are highly found on the human TERT gene promoter [37, 38]. Thus, 
cancer-causing mutations are not only present in the protein-coding genes, but also 
in the gene expression regulatory regions.
Transcriptome analysis does not only contribute to the diagnosis or prognosis of 
cancer but also other human diseases. For example, different gene expression patterns 
have been shown in autism [39], type 2 diabetes (T2DB) [40], schizophrenia [41], and 
neurodegenerative disease, including Alzheimer’s disease (AD) [42, 43]. Accumulation of 
repeat containing RNAs in aberrant foci in nucleus has been observed in Huntington dis-
ease, muscular dystrophy, and amyotrophic lateral sclerosis (ALS) [44]. The noncoding 
RNAs (ncRNAs), the long ncRNAs (lncRNAs), or long intergenic ncRNAs (lincRNAs) 
play essential roles in epigenetic regulation and in conversion of the nuclear structures 
[45]. Therefore, not only the protein encoding genes but also the ncRNAs are thought 
to be involved in the pathogenesis [46–48]. The lncRNAs control chromatin structure 
and nuclear architecture to regulate transcription in eukaryotic cells [49]. Thus, it is very 
important to explore how the lncRNAs are being regulated. Conversely, introduction of 
lncRNAs could be applied for treatment of specific diseases.
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5. Application of transcriptional control on medical sciences
Varieties of human diseases could be caused by the dysregulation in transcrip-
tion of either or both protein-encoding genes and ncRNAs. Although, it has not 
been examined if alteration in transcription is applicable for treatment of the 
presently intractable diseases, it will be possible in principle. A number of natural 
and chemical compounds could affect gene expression. Alternatively, transcrip-
tion could be modulated by the introduction of expression vectors, which express 
specific TFs in the target cells. In an effort to reach that goal, we have to develop 
reliable methods to deliver genes into abnormal or lesion cells.
5.1 Natural and the derivative compounds that regulate transcription
Natural compounds or phytochemicals could be applied on treatment of specific 
diseases. Some of them affect the JAK/STAT signaling pathway that activates cell 
cycle/proliferation-controlling factor-encoding gene expression [50]. Sulforaphane 
targets Nrf2 [51], which responds to oxidative stress, implying that it can be 
applied for the treatment of metabolic syndromes [52]. Tannic acid, coumarins, 
and chalcones suppress 12-O-tetra decanoylphorbol-13-acetate (TPA)-induced 
HIV promoter activity in human Jurkat cells [53]. Rsv induces promoter activities 
of DNA-repair factor-encoding genes, including TP53, WRN, TERT, and HELB 
[54–56]. The GGAA-containing motif and the GC-box have been suggested to play 
an essential role in the response. Vitamin E and the related compounds, including 
tocotrienols, activate transcription by binding to estrogen receptors [57] but inacti-
vate NF-κB activity [58]. Curcumin, which is a diferuloylmethane from the Indian 
spice turmeric, also targets NF-κB and AP1 to affect survival and proliferation of 
cells [59], might be applied on the suppression of the APP and the beta-site APP 
cleaving enzyme 1-encoding BACE1 gene expression [60].
These observations imply that phytochemicals could be used for therapeutic 
use. To minimize side effects, how the molecular mechanisms affect transcription 
should be elucidated. Next-generation therapies for intractable human diseases 
might be enabled by introduction of TF-expression vectors or by editing specific 
site(s) of the genome. Additionally, nucleotides or nucleic acid-based pharmaceuti-
cal compounds might be developed to ameliorate profile or status of gene expres-
sion in dysregulated cells.
5.2 Dysregulation in transcription might cause aging-related diseases
Indeed, aging is not a disease in principle. However, incidences of specific 
diseases are increased according to the process, for example, arteriosclerosis, cancer, 
sarcopenia, and neurodegenerative diseases, including AD. The causations of aging 
have been studied and discussed at the cellular level and they could be classified as 
follows:
5.2.1 Genome instability, including telomere shortening
Aging is thought to be accelerated by the accumulation of damage on chromo-
somal DNAs. This hypothesis is supported by the identification of responsive genes 
for premature aging, for example, LMNA, WRN, ATM, and SRPTN [61, 62].  
Therefore, the aberrances in the nuclear architecture and DNA repair systems may 
cause premature aging. Cellular senescence is generally accompanied with the 
shortening of telomeres [63]. This is consistent with the observations that short-
ened telomeres cause genomic instabilities.
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5.2.2 Accumulation of damage from oxidative stresses
Neurotoxicity could be induced by numbers of factors. The oxidative stress 
or the oxidative damage would cause neurodegenerative diseases, including the 
AD. The oxidative stresses impact on the Keap1-NRF2-ARE signaling pathway to 
upregulate expression of stress response genes, such as NRF2, KEAP1, SOD1, and 
ETS1 [64]. The observation is consistent with the theory that the incidence of the 
AD increases with the aging [65].
5.2.3 Mitochondrial dysregulations and dysfunctions
Morphology of mitochondria and the respiratory functions are declined by 
aging process, accompanied with the accumulation of mitochondrial DNAs (mtD-
NAs) [66, 67]. The mutations on the mtDNAs are thought to be partly caused by 
the oxidative stresses. Nuclear-mitochondrial communication is thought to play a 
role in the regulation of longevity [68]. Moreover, telomere dysfunctions induce 
mitochondrial compromise [69]. In summary, interplay between mitochondria and 
nuclei would affect aging.
5.2.4 Decrease in the cellular NAD+ level
Nicotine amide adenine dinucleotide (NAD+), which is required for the respira-
tory functions of mitochondria, regulating enzymes in TCA cycle, and oxidative 
phosphorylation (OXPHOS), is declined with aging [70, 71]. The NAD+ activates 
protein deacetylase Sirtuins, which regulate health span and life span. Moreover, 
the NAD+ is a substrate for poly(ADP-ribose) (PARP), which plays an essential role 
in the DNA damage response [31].
5.2.5 Alteration in the epigenetic regulations of the genomes
The profiles of the methylation of DNAs and the modifications, including acety-
lation and methylation of histones, are altered in the aging process [72, 73]. These 
epigenetic changes will enhance or reduce transcription of specific genes.
5.2.6 Alterations in immune response and cytokine dysregulation
Cytokine dysregulation or prolonged inflammation is observed in aged person 
[74]. Numbers of proteins are involved in the inflammation process, suggesting 
that expression and degradation of proteins could accelerate or decelerate cellular 
senescence.
Aging might start from subtle changes in the TFs profile that regulate expression 
of genes encoding DNA-repair/mitochondrial/immune response-associated protein 
factors [31, 75]. Decline in metabolites, which target DNA-binding proteins and 
ncRNAs [46–48] to modulate epigenetic systems [24–30], would accelerate aging. 
Given that alterations in the transcription could cause the aging, it could be slowed 
by manipulating TFs profile.
6. Concluding remarks and future prospects
Homeostasis or negative feedback is not only required for endocrine system 
but also for biochemical reactions. Metabolites, including sugars, lipids and amino 
acids, and ionic substrates need to be maintained within biologically significant 
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level. Similarly, nucleic acids and proteins should be appropriately managed being 
continuously synthesized and degraded. The equilibrium will gradually change 
in accordance with aging. Homeostasis in organs would play a role in the cancer 
generation [76]. Senescence can be metaphorically expressed as a walk on a balance 
beam that is narrowed afterward. The younger cells proliferate faster and respond 
to stresses with more accuracy than the older ones. After repeated proliferation, 
cells will reach the point where they cannot go forward but initiate aging. Somatic 
cells can acquire a pluripotency by incorporation of TFs. So, is it not possible to 
reverse aged or abnormal cells into younger or healthy cells? Then, what molecules 
(nucleic acids, proteins, etc.) are required and how they are introduced (by specific 
vectors, genome-editing systems, etc.) into cells? That should be answered for the 
next-generation therapeutics against aging-related diseases (Figure 1).
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Figure 1. 
Concept of the next-generation transcriptome-based therapeutics.
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